Variability and regulation of O6-alkylguanine-DNA alkyltransferase

Carcinogenesis

Volumn 24, Issue 4, 2003, Pages 625-635

  Margison, Geoffrey P ^a   Povey, Andrew C ^b   Kaina, Bernd ^c   Santibáñez Koref, Mauro F ^d  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; 6 O ALKYLGUANINE DNA ALKYLTRANSFERASE INHIBITOR; 6 O BENZYLGUANINE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CARMUSTINE; DEXAMETHASONE; TEMOZOLOMIDE; TRANSCRIPTION FACTOR AP 1; DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TRANSCRIPTION FACTOR;

ANTINEOPLASTIC ACTIVITY; CANCER PATIENT; CANCER PREVENTION; CARCINOGENESIS; CELL CULTURE; CHROMATIN STRUCTURE; DNA ALKYLATION; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; ENZYME PHOSPHORYLATION; GENE CONTROL; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAMMAL CELL; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; ALKYLATION; AMINO ACID SEQUENCE; CHEMISTRY; CHROMATIN; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PHYSIOLOGY; PROMOTER REGION; SEQUENCE HOMOLOGY;

ALKYLATION; AMINO ACID SEQUENCE; CHROMATIN; DNA; HUMANS; MOLECULAR SEQUENCE DATA; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS;

EID: 0038055835     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg005     Document Type: Review

References (143)

1. 6-methylguanine-DNA methyltransferase expression. Pharmacol. Ther., 74, 285-297.
2. 6-alkylguanine by alkyltransferases. Mutat. Res., 462, 83-100.
3. 6-methylguanine and the cytotoxicity of methylating agents. Mutat. Res., 462, 71-82.
4. 6-Alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. Bioessays, 24, 255-266.
5. + and methylation-tolerant mismatch repair compromised cells: facts and models. Mutat. Res., 381, 227-241.
6. 6-methylguanine DNA-methyltransferase in other organisms. Mutat. Res., 512, 67-84.
7. Kanugula,S. and Pegg,A.E. (2001) Novel DNA repair alkyltransferase from Caenorhabditis elegans. Environ. Mol. Mutagen., 38, 235-243.
8. 6-methylguanine-DNA methyltransferase gene. Nucleic Acids Res., 19, 6163-6167.
9. 6-methylguanine DNA methyltransferase (MGMT) expression in Mer+ human tumor cells. Carcinogenesis, 16, 2255-2257.
10. 6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments. Mol. Cell Biol., 11, 4660-4668.
11. 6-alkylguanine-DNA alkyltransferase: protection against alkylating agents and sensitization to dibromoalkanes. Carcinogenesis, 20, 2089-2094.
12. Kaina,B., Ochs,K., Grosch,S., Fritz,G., Lips,J., Tomicic,M., Dunkern,T. and Christmann,M. (2001) BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis. Prog. Nucleic Acid Res. Mol. Biol., 68, 41-54.
13. 6-Benzylguanine and its role in chemotherapy. Clin. Cancer Res., 3, 837-847.
14. 6-methylguanine-DNA methyltransferase is a negative regulator of estrogen receptor-mediated transcription upon alkylation DNA damage. Mol. Cell Biol., 21, 7105-7114.
15. Tsuzuki,T., Sakumi,K., Shiraishi,A., Kawate,H., Igarashi,H., Iwakuma,T., Tominaga,Y., Zhang,S., Shimizu,S. and Ishikawa,T.A. (1996) Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent. Carcinogenesis, 17, 1215-1220.
16. 6-methylguanine-DNA methyltransferase. Proc. Natl Acad. Sci. USA, 98, 12566-12571.
17. 6-methylguanine-DNA methyltransferase. Jpn. J. Cancer Res., 91, 1085-1089.
18. 6-alkylguanine-DNA alkyltransferase. Science, 259, 219-222.
19. 6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. Proc. Natl Acad. Sci. USA, 90, 6468-6472.
20. Zaidi,N.H., Pretlow,T.P., O'Riordan,M.A., Dumenco,L.L., Allay,E. and Gerson,S.L. (1995) Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis, 16, 451-456.
21. 6-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis. Cancer Res., 56, 3244-3249.
22. 6-methylguanine-DNA methyltransferase protects against skin tumor formation induced by antineoplastic chloroethylnitrosourea. Cancer Res., 57, 3335-3338.
23. 6-alkylguanine-DNA alkyltransferases are hypersensitive to dibromoalkanes. Chem. Res. Toxicol., 12, 544-551.
24. 6-alkylguanine-DNA alkyltransferase in promoting 1,2-dibromoethane-induced genotoxicity in Escherichia coli. Mutat. Res., 452, 1-10.
25. Abril,N., Luque-Romero,F.L., Prieto-Alamo,M.J., Rafferty,J.A., Margison,G.P. and Pueyo,C. (1997) Bacterial and mammalian DNA alkyltransferases sensitize Escherichia coli to the lethal and mutagenic effects of dibromoalkanes. Carcinogenesis, 18, 1883-1888.
26. 6-alkylguanine-DNA alkyltransferase. J. Biol. Chem., 277, 37920-37928.
27. 6-Alkylguanine-DNA alkyltransferase activity in schistosomiasis-associated human bladder cancer. Eur. J. Cancer, 30A, 1314-1319.
28. Kyrtopoulos,S.A. (1998) DNA adducts in humans after exposure to methylating agents. Mutat. Res., 405, 135-143.
29. 6-alkylguanine-DNA alkyltransferase deficient cells. Carcinogenesis, 18, 1561-1567.
30. 6-methylguanine in DNA. Cancer Res., 57, 366-369.
31. Rydberg,B. and Lindahl,T. (1982) Nonenzymatic methylation of DNA by the intracellular methyl group donor S-adenosyl-L-methionine is a potentially mutagenic reaction. EMBO J., 1, 211-216.
32. Barrows,L.R. and Magee,P.N. (1982) Nonenzymatic methylation of DNA by S-adenosylmethionine in vitro. Carcinogenesis, 3, 349-351.
33. Bartsch,H. and Montesano,R. (1984) Relevance of nitrosamines to human cancer. Carcinogenesis, 5, 1381-1393.
34. 6-methylguanine methyltransferase activity and cellular sensitivity to alkylating agents in cell strains derived from a variety of animal species. Mutat. Res., 184, 161-168.
35. Day,R.S. III, Ziolkowski,C.H., Scudiero,D.A., Meyer,S.A., Lubiniecki,A.S., Girardi,A.J., Galloway,S.M. and Bynum,G.D. (1980) Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature, 288, 724-727.
36. 6-methylguanine from DNA of normal and xeroderma pigmentosum-derived lymphoblastoid lines. Nature, 289, 417-420.
37. 6-methylguanine-DNA methyltransferase (MGMT) activity in mammalian cells: a pre-molecular view. Mutat. Res., 233, 139-150.
38. 6-alkylguanine-DNA alkyltransferase activity in peripheral blood lymphocytes: relationship between this activity in lymphocytes and in lymphoblastoid lines from normal controls and from patients with Hodgkin's disease or non-Hodgkin's lymphoma. Cancer Res., 49, 5339-5344.
39. Arita,I., Tachibana,A., Takebe,H. and Tatsumi,K. (1989) Predominance of Mex+ cells in newly-established human lymphoblastoid cell lines. Carcinogenesis, 10, 2067-2073.
40. 6-methylguanine-DNA methyltransferase expression during immortalization of cloned human fibroblasts. Carcinogenesis, 17, 219-224.
41. 6-methylguanine-DNA methyltransferase during immortalization of human fibroblasts. Carcinogenesis, 11, 185-187.
42. + in human lymphoblastoid cells. Carcinogenesis, 11, 1733-1738.
43. - phenotype in human lymphoblastoid cell lines. Mutat. Res., 208, 167-172.
44. 6-methylguanine-DNA methyltransferase in C3H/10T1/2 cells. Carcinogenesis, 7, 807-812.
45. 6-methylguanine and the stimulation of DNA synthesis and growth of cultured chick hepatocytes. Carcinogenesis, 13, 33-39.
46. 6-Methylguanine repair of methylated DNA in vitro: cell cycle-dependence of rat liver methyltransferase activity. J. Cancer Res. Clin. Oncol., 110, 98-102.
47. Bouziane,M., Miao,F., Bates,S.E., Somsouk,L., Sang,B.C., Denissenko,M. and O'Connor,T.R. (2000) Promoter structure and cell cycle dependent expression of the human methylpurine-DNA glycosylase gene. Mutat. Res., 461, 15-29.
48. Pieper,R.O., Lester,K.A. and Fanton,C.P. (1999) Confluence-induced alterations in CpG island methylation in cultured normal human fibroblasts. Nucleic Acids Res., 27, 3229-3235.
49. 6-Alkylguanine-DNA alkyltransferase activity in normal human tissues and cells. Cancer Res., 44, 2855-2857.
50. 6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis, 7, 745-749.
51. 6-Methylguanine-DNA methyltransferase in pediatric primary brain tumors: relation to patient and tumor characteristics. Clin. Cancer Res., 7, 613-619.
52. 6-Methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics. Cancer Res., 58, 1068-1073.
53. 6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors. Proc. Natl Acad. Sci. USA, 93, 6941-6946.
54. 6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res., 53, 3416-3420.
55. 6-methylguanine-DNA methyltransferase in relation to p53 status and therapeutic response in ovarian cancer. Int. J. Cancer, 84, 388-395.
56. 6-methylguanine-DNA methyltransferase activity in the human lung persists with advancing age. Gerontology, 40 (suppl. 2), 3-9.
57. 6-alkylguanine-DNA alkyltransferase activity in circulating blood mononuclear cells of healthy human subjects. Int. J. Cancer, 91, 60-66.
58. 6-alkylguanine-DNA alkyltransferase expression in rat mammary epithelial cells. Cancer Lett., 75, 11-18.
59. 6-alkylguanine-DNA alkyltransferase gene is elevated in human breast tumor cells. Anticancer Res., 17, 4311-4315.
60. 6-Methylguanine-DNA methyltransferase in normal and malignant tissue of the breast. Cancer Invest., 12, 605-610.
61. 6-methylguanine-DNA methyltransferase in human tumor and corresponding normal tissue. Cancer Detect. Prev., 20, 130-136.
62. 6-Alkylguanine-DNA alkyltransferase in normal colon tissue and colon cancer. Oncol. Res., 9, 149-153.
63. 6-alkylguanine-DNA alkyltransferase activity in normal and tumour tissue from human colon and rectum. Int. J. Cancer, 85, 68-72.
64. 6-alkylguanine-DNA alkyltransferase activity in human colon cancer. Clin. Cancer Res., 1, 519-525.
65. Esteller,M., Garcia-Foncillas,J., Andion,E., Goodman,S.N., Hidalgo,O.F., Vanaclocha,V., Baylin,S.B. and Herman,J.G. (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N. Engl. J. Med., 343, 1350-1354.
66. 6-alkylguanine DNA-alkyltransferase expression in human breast tumours. Br. J. Cancer, 86, 1797-1802.
67. 6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. Br. J. Cancer, 78, 1199-1202.
68. 6-methylguanine DNA methyltransferase in chronic liver diseases. Alcohol Clin. Esp. Res., 20, 297A-300A.
69. 6-methylguanine in cirrhosis. J. Hepatol., 25, 158-165.
70. 6-alkylguanine-DNA-alkyltransferase in hepatitis B cirrhotic human liver: a potential cofactor in the development of hepatocellular carcinoma. Hepatology, 24, 987-990.
71. 6-alkylguanine in mammalian systems. In Seeberg,E. and Kleepe,K. (eds), Chromosome Damage and Repair. Plenum Press, New York, London.
72. 6-alkylguanine repair in rodents. Biochimie, 64, 769-773.
73. Grombacher,T., Mitra,S. and Kaina,B. (1996) Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes. Carcinogenesis, 17, 2329-2336.
74. - cells. Cancer Res., 52, 6404-6406.
75. 6-alkylguanine-DNA-alkyltransferase gene, molecular analysis of expression in rat liver. Carcinogenesis, 12, 727-733.
76. 6-methylguanine-DNA methyltransferase in C3H/10T1/2 cells by X-rays is inhibited by nitrogen. Carcinogenesis, 9, 679-681.
77. 6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in rat liver cells exhibiting different status of differentiation. Biochim. Biophys. Acta, 1270, 63-72.
78. 6-methylguanine-DNA methyltransferase mRNA in rat hepatoma cells. Biochim. Biophys. Acta, 1171, 35-40.
79. Laval,F. (1990) Induction of proteins involved in the repair of alkylated bases in mammalian cells by DNA-damaging agents. Mutat. Res., 233, 211-218.
80. 6-methylguanine-DNA-methyltransferase activity in a rat hepatoma cell line by poly (ADP-ribose) synthesis inhibitors. Biochem. Biophys. Res. Commun., 163, 599-604.
81. 6-alkylguanine-DNA alkyltransferase activity in human lung tissue. Carcinogenesis, 15, 1535-1539.
82. 6-methylguanine-DNA methyltransferase and uracil-DNA glycosylase in human placentae from smokers and non-smokers. Carcinogenesis, 13, 1769-1773.
83. 6-methylguanine-DNA methyltransferase expression in human lung carcinomas. Carcinogenesis, 19, 1247-1250.
84. 6-Methylguanine-DNA methyltransferase content in human lymphocytes following surgical trauma. Biochem. Med. Metab. Biol., 41, 171-176.
85. 6-Alkylguanine DNA alkyltransferase activity in student embalmers. Am. J. Ind. Med., 31, 361-365.
86. 6-methylguanine. Cancer Res., 52, 1801-1803.
87. 6-methylguanine-DNA methyltransferase gene in young patients with adult type cancers and functional assay. Carcinogenesis, 16, 2441-2445.
88. 6-benzylguanine. Cancer Res., 56, 5571-5575.
89. 6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer. Clin. Cancer Res., 5, 209-213.
90. 6-alkylguanine DNA alkyltransferase gene in lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 9, 339-342.
91. Inoue,R., Abe,M., Nakabeppu,Y., Sekiguchi,M., Mori,T. and Suzuki,T. (2000) Characterization of human polymorphic DNA repair methyltransferase. Pharmacogenetics, 10, 59-66.
92. 6-methylguanine-DNA methyltransferase (MGMT) and N-methylpurine-DNA glycosylase (MPG) in lung cancer patients from Poland. Hum. Mutat., 14, 269-270.
93. Rasheed,B.K., Wiltshire,R.N., Bigner,S.H. and Bigner,D.D. (1999) Molecular pathogenesis of malignant gliomas. Curr. Opin. Oncol., 11, 162-167.
94. 6-methylguanine-DNA methyltransferase gene in esophageal cancer tissues from Northern China. Int. J. Cancer, 71, 719-723.
95. 6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling. Cancer Res., 58, 3950-3956.
96. 6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone. Oncogene, 18, 525-532.
97. 6-methylguanine-DNA methyltransferase enhancer binding protein in DNA repair-deficient human cells. Proc. Natl Acad. Sci. USA, 94, 4348-4353.
98. 6-alkylguanine-DNA-alkyltransferase in response to ionising radiation is p53 gene dose dependent. Oncogene, 12, 693-697.
99. 6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents. Oncogene, 17, 845-851.
100. 6-methylguanine-DNA methyltransferase gene. Cancer Res., 56, 2029-2032.
101. 6-Methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation. Int. J. Cancer, 84, 416-420.
102. 6-methylguanine-DNA methyltransferase gene by transcriptional coactivators cAMP response element-binding protein-binding protein and p300. J. Biol. Chem., 275, 34197-34204.
103. 6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning. Mol. Cell Biol., 17, 5813-5822.
104. 6-methylguanine-DNA methyltransferase gene in cultured human tumor cells. Mutat. Res., 273, 221-230.
105. Christmann,M., Pick,M., Lage,H., Schadendorf,D. and Kaina,B. (2001) Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT. Int. J. Cancer, 92, 123-129.
106. 6-methylguanine-DNA methyltransferase promoter in immortalized IMR90 cell lines. Int. J. Oncol., 18, 1187-1193.
107. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res., 59, 793-797.
108. 6-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J. Natl Cancer Inst., 94, 26-32.
109. 6-methylguanine-DNA methyltransferase in human lung adenocarcinoma relates to high-grade histology and worse prognosis among smokers. Jpn. J. Cancer Res., 93, 184-189.
110. 6-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer, 92, 2760-2768.
111. 6-alkylguanine-DNA alkyltransferase in human brain tumor cells. Cancer Res., 60, 282-287.
112. 6-alkylguanine-DNA alkyltransferase is phosphorylated by two distinct and novel protein kinases in human brain tumour cells. Biochem. J., 351(Pt 2), 393-402.
113. Lim,I.K., Park,T.J. and Paik,W.K. (2000) Phosphorylation of methylated-DNA-protein-cysteine S-methyltransferase at serine-204 significantly increases its resistance to proteolytic digestion. Biochem. J., 352 (Pt 3), 801-808.
114. Gerson,S.L. (2002) Clinical relevance of MGMT in the treatment of cancer. J. Clin. Oncol., 20, 2388-2399.
115. 6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair. Cancer Res., 59, 2402-2410.
116. 6-benzylguanine followed by carmustine in patients with advanced cancer. Clin. Cancer Res., 6, 3025-3031.
117. 6-benzylguanine for patients undergoing surgery for malignant glioma. J. Clin. Oncol., 16, 3570-3575.
118. Roth,R.B. and Samson,L.D. (2000) Gene transfer to suppress bone marrow alkylation sensitivity. Mutat. Res., 462, 107-120.
119. 6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents. Gene Ther., 6, 1489-1493.
120. Encell,L.P., Coates,M.M. and Loeb,L.A. (1998) Engineering human DNA alkyltransferases for gene therapy using random sequence mutagenesis. Cancer Res., 58, 1013-1020.
121. 6-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma. J. Clin. Oncol., 20, 2277-2283.
122. 6-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors. Int. J. Cancer, 93, 373-379.
123. Baum,C., Margison,G.P., Eckert,H.G., Fairbairn,L.J., Ostertag,W. and Rafferty,J.A. (1996) Gene transfer to augment the therapeutic index of anticancer chemotherapy. Gene Ther., 3, 1-3.
124. 6-alkylguanine-DNA-alkyltransferases. Curr. Gene Ther., 2, 1-8.
125. Janssen,K., Eichhorn-Grombacher,U., Schlink,K., Nitzsche,S., Oesch,F. and Kaina,B. (2001) Long-time expression of DNA repair enzymes MGMT and APE in human peripheral blood mononuclear cells. Arch. Toxicol., 75, 306-312.
126. 6-Methylguanine-DNA methyltransferase in lymphocytes of the elderly with and without Alzheimer's disease. Mutat. Res., 219, 267-272.
127. 6-Methylguanine-DNA methyltransferase in human fetal tissues: fetal and maternal factors. Cancer Res., 47, 51-55.
128. 6-methylguanine-DNA methyltransferase and uracil-DNA glycosylase activities. Mutat. Res., 131, 183-186.
129. Hall,J., Bresil,H., Donato,F., Wild,C.P., Loktionova,N.A., Kazanova,O.I., Komyakov,I.P., Lemekhov,V.G., Likhachev,A.J. and Montesano,R. (1993) Alkylation and oxidative-DNA damage repair activity in blood leukocytes of smokers and non-smokers. Int. J. Cancer, 54, 728-733.
130. 6-Methylguanine-DNA methyltransferase and uracil DNA glycosylase in human broncho-alveolar lavage cells and peripheral blood mononuclear cells from tobacco smokers and non-smokers. Carcinogenesis, 12, 1389-1394.
131. 6-alkyltransferase activity and on gastric vitamin C levels. Cancer Lett., 86, 159-165.
132. 4-ethylthymine in human liver and peripheral blood leukocyte DNA. Carcinogenesis, 16, 1277-1280.
133. 6-Methylguanine in blood leucocyte DNA: an association with the geographic prevalence of gastric cancer and with low levels of serum pepsinogen A, a marker of severe chronic atrophic gastritis. Carcinogenesis, 15, 1815-1820.
134. 6-methylguanine in human peripheral and cord blood DNA. Cancer Epidemiol. Biomarkers Prev., 9, 299-305.
135. 6-methyldeoxyguanosine in human placental DNA. Cancer Res., 48, 4184-4188.
136. Wilson,V.L., Weston,A., Manchester,D.K., Trivers,G.E., Roberts,D.W., Kadlubar,F.F., Wild,C.P., Montesano,R., Willey,J.C. and Mann,D.L. (1989) Alkyl and aryl carcinogen adducts detected in human peripheral lung. Carcinogenesis, 10, 2149-2153.
137. 6-methylguanine, in normal DNA from the cancer prone regions of the large bowel. Gut, 47, 362-365.
138. 6-Methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. Int. J. Cancer, 36, 661-665.
139. Hall,C.N., Badawi,A.F., O'Connor,P.J. and Saffhill,R. (1991) The detection of alkylation damage in the DNA of human gastrointestinal tissues. Br. J. Cancer, 64, 59-63.
140. 6-alkylguanine-DNA-alkyltransferase in situ in ovarian and Hodgkin's tumours. Eur. J. Cancer, 29A, 1306-1312.
141. 6-alkylguanine-DNA-alkyltransferase based on the use of an oligonucleotide substrate, and its application to the measurement of DNA repair activity in extracts of biopsy samples of human urinary bladder mucosa. Carcinogenesis, 10, 1203-1208.
142. 6-alkylguanine-DNA-alkyltransferase repair activity in normal and neoplastic human tissues. Comp. Biochem. Physiol. B, 101, 269-275.
143. 6-Methylguanine-DNA methyltransferase activity in human tumors. Carcinogenesis, 13, 1503-1507.